Skip to main content
. 2018 Mar 13;9:479. doi: 10.3389/fimmu.2018.00479

Table 2.

Blister fluid (BF) immunological characteristics (A) and correlation between serum and BF autoantibody titers (B) in patients with BP according to mucosal involvement.

All BP patients Patients without mucosal involvement Patients with mucosal involvement Pvalue
(A)

Number of patients (n)a 37 30 7 NA
BF anti-BP180 NC16A
Number of patients with titer ≥9 U/mL, n (%) 32 (86.5) 26 (86.7) 6 (85.7) 0.95
Mean value ± SD (U/mL) 79.4 ± 51.2 78.5 ± 51.8 83.5 ± 52.2 0.66
BF anti-BP230
Number of patients with titer ≥9 U/mL, n (%) 16 (43.2) 14 (46.7) 2 (28.7) 0.38
Mean value ± SD (U/mL) 31.2 ± 40.3 34.2 ± 41.5 18.2 ± 34.2 0.65

(B)

Number of patientsa 37 30 7
Anti-BP180 NC16A r = 0.78 r = 0.74 r = 0.89
P < 0.0001 P < 0.0001 P = 0.01
Anti-BP230 r = 0.73 r = 0.74 r = 0.75
P < 0.0001 P < 0.0001 P = 0.07

Subsets of BP patients with or without mucosal involvement were compared and P-value was calculated using Chi2 tests for comparison between qualitative variables and nonparametric, Mann–Whitney tests for comparison between quantitative values. Spearman’s correlation coefficient was used to explore the relationship between immunological parameters in serum with those in BF.

aPatient for whom BF and serum anti-BP180 NC16A and anti-BP230 ELISA values were available.

NA, not applicable; BP, bullous pemphigoid; ELISA, enzyme-linked immunosorbent assay.